167 related articles for article (PubMed ID: 24863090)
21. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
Do Cao C; Wémeau JL
Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
[TBL] [Abstract][Full Text] [Related]
22. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[TBL] [Abstract][Full Text] [Related]
23. Changes in quality of life after thyroidectomy in subjects with thyroid cancer in relation to the dose of levothyroxine.
Monzani ML; Piccinini F; Boselli G; Corleto R; Margiotta G; Peeters RP; Simoni M; Brigante G
J Endocrinol Invest; 2023 Feb; 46(2):319-326. PubMed ID: 35988109
[TBL] [Abstract][Full Text] [Related]
24. Does low serum TSH within the normal range have negative impact on physical exercise capacity and quality of life of healthy elderly people?
Chachamovitz DS; Vigário Pdos S; Carvalho RC; Silvestre DH; Moerbeck AE; Soffientini MG; Luna ÉL; Rosemberg CW; Mainenti MR; Vaisman M; Teixeira Pde F
Arch Endocrinol Metab; 2015 Jul; 60(3):236-45. PubMed ID: 26222231
[TBL] [Abstract][Full Text] [Related]
25. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
[TBL] [Abstract][Full Text] [Related]
26. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment.
Tagay S; Herpertz S; Langkafel M; Erim Y; Freudenberg L; Schöpper N; Bockisch A; Senf W; Görges R
Eur J Endocrinol; 2005 Dec; 153(6):755-63. PubMed ID: 16322380
[TBL] [Abstract][Full Text] [Related]
28. Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine.
Traub-Weidinger T; Graf S; Beheshti M; Ofluoglu S; Zettinig G; Khorsand A; Nekolla SG; Kletter K; Dudczak R; Pirich C
Thyroid; 2012 Mar; 22(3):245-51. PubMed ID: 22233129
[TBL] [Abstract][Full Text] [Related]
29. Quality of Life, Anxiety and Depression in Patients with Differentiated Thyroid Cancer under Short Term Hypothyroidism Induced by Levothyroxine Withdrawal.
Badihian S; Jalalpour P; Mirdamadi M; Moslehi M
Klin Onkol; 2016; 29(6):439-444. PubMed ID: 27951721
[TBL] [Abstract][Full Text] [Related]
30. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
31. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
32. [Postoperative surveillance of differentiated thyroid epithelioma. Contribution of the ultrasensitive determination of TSH].
Schlumberger M; De Vathaire F; Wu-Ahouju G; Comoy E; Fragu P; Parmentier C
Presse Med; 1987 Oct; 16(36):1791-3. PubMed ID: 2962104
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma].
Rajkovaca Z; Kovacević P; Stanetić M; Ristić S
Vojnosanit Pregl; 2012 Nov; 69(11):941-6. PubMed ID: 23311243
[TBL] [Abstract][Full Text] [Related]
34. Five-Year Follow-Up of Health-Related Quality of Life in Differentiated Thyroid Cancer Patients Treated with Total Thyroidectomy and Radioiodine in Sweden: A Nationwide Prospective Cohort Study.
Winter J; Axelsson E; Björkhem-Bergman L; Ihre Lundgren C; Hedman C
Thyroid; 2024 Apr; ():. PubMed ID: 38526369
[No Abstract] [Full Text] [Related]
35. Quality of life assessment after central corpectomy for cervical spondylotic myelopathy: comparative evaluation of the 36-Item Short Form Health Survey and the World Health Organization Quality of Life-Bref.
Thakar S; Christopher S; Rajshekhar V
J Neurosurg Spine; 2009 Oct; 11(4):402-12. PubMed ID: 19929335
[TBL] [Abstract][Full Text] [Related]
36. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound.
Rosário PW; Bessa B; Valadão MM; Purisch S
Thyroid; 2009 Jan; 19(1):9-12. PubMed ID: 19021461
[TBL] [Abstract][Full Text] [Related]
37. Effect of Thyroid-Related Symptoms on Long-Term Quality of Life in Patients with Differentiated Thyroid Carcinoma: A Population-Based Study in Sweden.
Hedman C; Djärv T; Strang P; Lundgren CI
Thyroid; 2017 Aug; 27(8):1034-1042. PubMed ID: 28474541
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
39. Effects of aerobic, resistance, and combined training on thyroid function and quality of life in hypothyroidism. A randomized controlled trial.
Ahmad AM; Serry ZH; Abd Elghaffar HA; Ghazi HA; El Gayar SL
Complement Ther Clin Pract; 2023 Nov; 53():101795. PubMed ID: 37659172
[TBL] [Abstract][Full Text] [Related]
40. The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma.
Heemstra KA; Hamdy NA; Romijn JA; Smit JW
Thyroid; 2006 Jun; 16(6):583-91. PubMed ID: 16839260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
